Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Toft

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|June 20, 2025
[CRISPR as a functional cure for hemoglobinopathies]Andreas Glenthøj, Sarah Birgitte Ingemod Sand Carlsen, Marianne Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2013
Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trialThomas Leth Frandsen, Mats Heyman, Jonas Abrahamsson, et al.
BMJ Open|July 30, 2024
Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocolAndreas Glenthøj, Eduard J van Beers, Richard van Wijk, et al.
Pediatric Blood & Cancer|June 27, 2018
Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemiaSigne Sloth Mogensen, Arja Harila-Saari, Outi Mäkitie, et al.
Leukemia & Lymphoma|October 21, 2021
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based studyLars Klingen Gjærde, Cecilie Utke Rank, Mette Klarskov Andersen, et al.
European Journal of Haematology|April 14, 2015
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemiaNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
European Journal of Haematology|March 7, 2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocolNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
Haematologica|February 20, 2025
Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trialTuomas Lahteenmaki Taalas, Trausti Oskarsson, Mats Heyman, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2021
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyLinea Natalie Toksvang, Liv Andrés-Jensen, Cecilie Utke Rank, et al.
Blood|April 18, 2018
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 yearsCecilie Utke Rank, Nina Toft, Ruta Tuckuviene, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|June 20, 2025
[CRISPR as a functional cure for hemoglobinopathies]Andreas Glenthøj, Sarah Birgitte Ingemod Sand Carlsen, Marianne Hoffmann, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2013
Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trialThomas Leth Frandsen, Mats Heyman, Jonas Abrahamsson, et al.
BMJ Open|July 30, 2024
Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocolAndreas Glenthøj, Eduard J van Beers, Richard van Wijk, et al.
Pediatric Blood & Cancer|June 27, 2018
Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemiaSigne Sloth Mogensen, Arja Harila-Saari, Outi Mäkitie, et al.
Leukemia & Lymphoma|October 21, 2021
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based studyLars Klingen Gjærde, Cecilie Utke Rank, Mette Klarskov Andersen, et al.
European Journal of Haematology|April 14, 2015
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemiaNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
European Journal of Haematology|March 7, 2013
Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocolNina Toft, Henrik Birgens, Jonas Abrahamsson, et al.
Haematologica|February 20, 2025
Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trialTuomas Lahteenmaki Taalas, Trausti Oskarsson, Mats Heyman, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2021
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyLinea Natalie Toksvang, Liv Andrés-Jensen, Cecilie Utke Rank, et al.
Blood|April 18, 2018
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 yearsCecilie Utke Rank, Nina Toft, Ruta Tuckuviene, et al.
Pageof 3